Catheterization and Cardiovascular Interventions
Volume 100, Issue 6 pp. 1146-1147
COMMENTARY

Peripheral arterial disease and multisite atherosclerosis in patients undergoing percutaneous coronary intervention

Raffaele Piccolo MD, PhD, 

Raffaele Piccolo MD, PhD

Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy

Search for more papers by this author
Giovanni Esposito MD, PhD, 

Corresponding Author

Giovanni Esposito MD, PhD

Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy

UNESCO Chair on Health Education and Sustainable Development, University of Naples Federico II, Naples, Italy

Correspondence: Giovanni Esposito, Division of Cardiology, Department of Advanced Biomedical Sciences, UNESCO Chair on Health Education and Sustainable Development, University of Naples Federico II, Via S. Pansini, 5. Naples, Italy.

Email: [email protected]

Search for more papers by this author
First published: 29 November 2022
https://doi.org/10.1002/ccd.30478

Expert Article Analysis for: Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention

Key Points

  • Atherosclerosis is a systemic disease and frequently coronary artery disease is intertwined with peripheral arterial disease (PAD).

  • This large study showed that PAD and its extension (multisite atherosclerosis) negatively affects the risk of in-hospital mortality in patients with coronary artery disease undergoing PCI.

  • PAD status and its extension in the principal vascular territories should be carefully assessed during hospitalization for coronary revascularization and should be regarded as important risk factors.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.